Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Pharma
No surprise: Lilly, Novo Nordisk were top revenue gainers in Q3
The success of weight-loss drugs were the dominant story in pharma in Q3 as Eli Lilly (38%) and Novo Nordisk (29%) had the highest revenue gains.
Kevin Dunleavy
Nov 28, 2023 3:00am
Novo to invest $2.3B to expand production of GLP-1s in France
Nov 27, 2023 10:40am
Novo Nordisk to reduce supply of Victoza to make more Ozempic
Nov 22, 2023 10:55am
GSK aims to slash carbon emissions with next-generation inhaler
Nov 21, 2023 10:16am
Export of Novo Nordisk's Ozempic could be banned in Germany
Nov 15, 2023 11:07am
UPDATED: Novo serves Lilly with obesity head-to-head trial
Nov 15, 2023 10:55am
